Form 4: Longeveron Inc. Director Joshua Hare Acquires Shares and Stock Options
SEC Form 4 Filing
Director and Chief Scientific Officer Joshua Hare reports acquisition of shares and stock options in Longeveron Inc.
Summary
- On August 15, 2024, Joshua Hare, a director, 10% owner, and the Chief Scientific Officer of Longeveron Inc. (LGVN), reported transactions involving the company's securities.
- Hare acquired 93,766 shares of Class A Common Stock at $0, consisting of two time-based vesting Restricted Stock Unit (RSU) awards.
- Following these transactions, Hare beneficially owns 727,046 shares, which includes 462,807 shares of Class B common stock.
- Hare also acquired 6,500 stock options with an exercise price of $2.46, exercisable quarterly over three years starting October 1, 2024, and expiring on August 15, 2034.
- After the transaction, Hare beneficially owns 6,500 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard disclosure of insider transactions. The acquisition of shares and options could be seen as a positive sign, but it's not explicitly indicative of strong positive sentiment.
Positives
- The acquisition of shares and stock options by a director and officer may signal confidence in the company's future prospects.
Future Outlook
The document does not contain specific forward-looking statements, but the vesting schedule of the stock options extends to August 15, 2034.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company insiders and their holdings.
Comparison to Industry Standards
- Form 4 filings are standard practice for publicly traded companies in the US, ensuring transparency of insider transactions.
- Similar filings are made by executives at companies like BioNTech, Moderna, and other biotech firms, reflecting stock and option grants as part of their compensation packages.
Stakeholder Impact
- The transactions may have a minor positive impact on shareholder sentiment due to the insider's increased stake in the company.
Key Dates
| Date | Description |
|---|---|
| 08/15/2024 | Date of earliest transaction: Acquisition of Class A Common Stock and stock options. |
| 10/01/2024 | Start date for quarterly vesting of stock options over a three-year period. |
| 08/15/2034 | Expiration date of the acquired stock options. |
| 08/19/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.